References: Candidaemia (including Candida and related species sepsis)

  • Boonstra JM, Martson AG, Sandaradura I, Kosterink JGW, van der Werf TS, Marriott DJE, et al. Optimization of fluconazole dosing for the prevention and treatment of invasive candidiasis based on the pharmacokinetics of fluconazole in critically ill patients. Antimicrob Agents Chemother 2021;65(3). https://www.ncbi.nlm.nih.gov/pubmed/33361296
  • Borman AM, Johnson EM. Name changes for fungi of medical importance, 2018 to 2019. J Clin Microbiol 2021;59(2). https://www.ncbi.nlm.nih.gov/pubmed/33028600
  • Domingos EL, Vilhena RO, Santos J, Fachi MM, Boger B, Adam LM, et al. Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses. Int J Antimicrob Agents 2022;60(2):106614. https://www.ncbi.nlm.nih.gov/pubmed/35691603
  • Gabardi S, Martin S, Sura M, Mohammed A, Golan Y. Micafungin treatment and eradication of candiduria among hospitalized patients. Int Urol Nephrol 2016;48(11):1881-5. https://www.ncbi.nlm.nih.gov/pubmed/27587066
  • Kane LE, Muzevich KM. Micafungin in the treatment of candiduria: A case series. Med Mycol Case Rep 2016;11:5-8. https://www.ncbi.nlm.nih.gov/pubmed/26937340
  • Keighley C, Cooley L, Morris AJ, Ritchie D, Clark JE, Boan P, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J 2021;51 Suppl 7:89-117. https://www.ncbi.nlm.nih.gov/pubmed/34937142
  • Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62(4):e1-50. https://www.ncbi.nlm.nih.gov/pubmed/26679628
  • Rkieh L, El Nekidy WS, Alsoud LO, Alatoom A, El Lababidi R, Mooty M, et al. Outcomes of caspofungin use in the treatment of Candida-related urinary tract infections, a case series. IDCases 2022;28:e01510. https://www.ncbi.nlm.nih.gov/pubmed/35646592
  • Sandaradura I, Marriott DJE, Day RO, Norris RLG, Pang E, Stocker SL, et al. Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy. Eur J Clin Microbiol Infect Dis 2021;40(7):1521-8. https://www.ncbi.nlm.nih.gov/pubmed/33638727
  • Sobel JD, Bradshaw SK, Lipka CJ, Kartsonis NA. Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis 2007;44(5):e46-9. https://www.ncbi.nlm.nih.gov/pubmed/17278048